« Return to News | R&D Trends

Boehringer builds $42.5 million R&D facility

Thursday, August 25, 2011 10:57 AM

Boehringer Ingelheim Pharmaceuticals, broke ground on a new $42.5-million safety assessment building to be built over the next two years on its 294-acre campus in Ridgefield and Danbury, according to the Ridgefield Press.

The building, when completed in 2013, will provide more than 63,000 square feet of space for non-clinical safety studies in development as well as studies for research.

“The fact that Boehringer Ingelheim continues to invest in its campus and create jobs is great news for Connecticut,” said Connecticut Gov. Malloy. “This new facility expands the company’s research and development capacities, and reaffirms its reputation as an innovative and forward-looking company. Boehringer Ingelheim is a valued member of the Connecticut business community and a key partner in our collective efforts to strengthen the state’s bioscience industry.”

This new facility is a world class design combining state-of-the-art technology, compliance with current good manufacturing practice and process flexibility to handle production of the many different types of APIs discovered in research, Boehringer said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.